CYTOMX THERAPEUTICS, INC. Shares of Common Stock (par value $0.00001 per share) Controlled Equity OfferingSM Sales AgreementCytomX Therapeutics, Inc. • November 3rd, 2016 • Pharmaceutical preparations • New York
Company FiledNovember 3rd, 2016 Industry JurisdictionCytomX Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: